Dawn Allen Sells 74,679 Shares of Haleon plc (LON:HLN) Stock

Haleon plc (LON:HLN) insider Dawn Allen sold 74,679 shares of Haleon stock in a transaction on Thursday, November 21st. The shares were sold at an average price of GBX 372 ($4.66), for a total value of £277,805.88 ($348,258.59).

Haleon Stock Up 2.1 %

LON HLN opened at GBX 380.30 ($4.77) on Friday. The stock’s 50 day simple moving average is GBX 379.25 and its 200 day simple moving average is GBX 357.45. Haleon plc has a one year low of GBX 308.37 ($3.87) and a one year high of GBX 400.65 ($5.02). The firm has a market cap of £34.38 billion, a PE ratio of 3,169.17, a price-to-earnings-growth ratio of 1.49 and a beta of 0.19. The company has a debt-to-equity ratio of 54.18, a current ratio of 0.84 and a quick ratio of 0.93.

Analyst Ratings Changes

Separately, Berenberg Bank increased their target price on shares of Haleon from GBX 410 ($5.14) to GBX 447 ($5.60) and gave the stock a “buy” rating in a research report on Monday, August 5th.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.